Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
Managing Paediatric Anxiety in General Practice
OSA – Which Test for Which Patient
Musculoskeletal Health in Menopause
AHPRA-Proof Your Practice – Social Media Risks for GPs
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis